Not yet taking people in EgyptPhase 4
Azithromycin added to ointments for children with atopic dermatitis
Tests adding azithromycin to skin ointments in children with mild to moderate eczema.
Plain-language title generated from the registry record
Registry title: Azithromycin in Atopic Dermatitis
Key facts
- Where
- Cairo, EgyptSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 12 years old?
Source: NCT07713186, who can take part
Where in Egypt
- Cairo UniversityCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT07713186
- Record updated
- 20 July 2026
- Original description
The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitisRead full original descriptionShow less
Evaluation of the Value of Adding Azithromycin to Topical Treatment in Mild to Moderate Atopic Dermatitis
The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis
Inclusion: Both genders, ages from 3 to 12 years old with mild to moderate atopic dermatitis.
Exclusion: Atopic dermatitis on active systemic treatment.